Status:

COMPLETED

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.

Lead Sponsor:

Purdue Pharma LP

Conditions:

Back Pain

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The objective of this study is to assess the safety of the buprenorphine transdermal system (5, 10, and 20) in comparison to placebo transdermal system and immediate release oxycodone/ acetaminophen i...

Detailed Description

Buprenorphine is a synthetic opioid analgesic with over twenty-five years of international clinical experience indicating it to be safe and effective in a variety of therapeutic situations for the rel...

Eligibility Criteria

Inclusion

  • clinical evidence of stable, chronic (\>2 months) back pain related to intervertebral disc disease, nerve root entrapment, spondylolithesis, and osteoarthritis or other, similar nonmalignant conditions.
  • unacceptable pain control despite currently taking a nonsteroidal anti-inflammatory drug considered at a therapeutic and/or tolerated dose or, subjects currently taking \</=2 short-acting opioid doses per day, or subjects taking 3-12 short-acting opioid doses per day.

Exclusion

  • receiving opioids at an average daily dose of \>90 mg of oral morphine equivalents or receiving more than 12 tablets per day of short-acting opioid-containing products.
  • scheduled to have surgery (including dental) involving the use of preoperative or postoperative analgesics or anesthetics during the study period.
  • Other protocol-specific exclusion/inclusion criteria may apply.

Key Trial Info

Start Date :

December 1 1997

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 1998

Estimated Enrollment :

134 Patients enrolled

Trial Details

Trial ID

NCT00315445

Start Date

December 1 1997

End Date

May 1 1998

Last Update

September 3 2012

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Rheumatology Associates of North Alabama

Huntsville, Alabama, United States, 35801

2

Phoenix Center for Clinical Research

Phoenix, Arizona, United States, 85015

3

Phoenix Orthopedic Center, Ltd.

Phoenix, Arizona, United States, 85023

4

Gainesville Clinical Research Center

Gainesville, Florida, United States, 32605